mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.04 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.05 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.05 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.05 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.05 |
mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.05 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.05 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |